Filana Therapeutics (FLNA) Price to Sales (2011 - 2026)
Filana Therapeutics' (FLNA) Price to Sales was 37.65 for Q4 2013, down 51.7% from 77.92 a year earlier and down 63.7% from the prior quarter.
Powered by 
Analysis
Filana Therapeutics (FLNA) Price to Sales (2011 - 2026) Analysis & Trends
Dating back to Q1 2011, Filana Therapeutics' Price to Sales record includes 12 quarters.
- Price to Sales has declined for three consecutive years.
- By year, Price to Sales came in at 77.92 in FY2012 (-24.8%), 103.61 in FY2011 (-14.1%), 120.62 in FY2010 (+56.8%) and 76.94 in FY2009.
- The Q4 2013 figure ranks as the lowest quarterly Price to Sales in data going back to Q1 2011.
- Year over year, Price to Sales has now declined in each of the last three quarters, with an average decline of 4.1% over the last eight quarters.
- The high point for year-over-year Price to Sales in five years was Q2 2012 (growth of 83.5%); the low point was Q4 2013 (a decline of 51.7%).
- Per Business Quant data, the three quarters before Q4 2013 came in at 103.70 (Q3 2013), 77.16 (Q2 2013) and 110.22 (Q1 2013).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Filana Therapeutics | 31.40 Mn | -339.44 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.63 |
| Mar 31, 2026 | 19.70 |
| Dec 31, 2025 | 20.70 |
| Sep 30, 2025 | 25.81 |
| Jun 30, 2025 | 12.68 |
| Mar 31, 2025 | 9.06 |
| Dec 31, 2024 | 13.37 |
| Sep 30, 2024 | 170.34 |
| Jun 30, 2024 | 77.19 |
| Mar 31, 2024 | 116.10 |
| Dec 31, 2023 | 121.38 |
| Sep 30, 2023 | 89.78 |
| Jun 30, 2023 | 153.85 |
| Mar 31, 2023 | 25.35 |
| Dec 31, 2022 | 31.11 |
| Sep 30, 2022 | 41.84 |
| Dec 31, 2013 | 37.65 |
| Sep 30, 2013 | 103.70 |
| Jun 30, 2013 | 77.16 |
| Mar 31, 2013 | 110.22 |
API Access
Filana Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=FLNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "FLNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=FLNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();